Search

Displaying results 4581 - 4590 of 6076 in total
  1. Drug

    Baicalein

    go.drugbank.com/drugs/DB16101
    Investigational

    Baicalein is under investigation in clinical trial NCT03830684 (A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase ⅡA Clinical Trial for the Effectiveness and Safety of Baicalein Tablets

  2. Drug

    OTL-102

    go.drugbank.com/drugs/DB18642
    Experimental

    It is being investigated for the treatment of X-linked chronic granulomatous disease.

  3. Drug

    Asundexian

    go.drugbank.com/drugs/DB19088
    Investigational

    Asundexian is under investigation in clinical trial NCT05686070 (A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk

  4. Drug

    MF-300

    go.drugbank.com/drugs/DB32060
    Investigational

    As a potential candidate for the treatment of sarcopenia, it has undergone phase 1 studies to evaluate safety, tolerability, and PK/PD characteristics.[A275368,L54983]

  5. Drug

    Cefbuperazone

    go.drugbank.com/drugs/DB13638
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  6. Drug

    Ceftezole

    go.drugbank.com/drugs/DB13821
    Investigational

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  7. Drug

    Cefatrizine

    go.drugbank.com/drugs/DB13266
    Investigational

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  8. Drug

    Pipamperone

    go.drugbank.com/drugs/DB09286
    Investigational

    Pipamperone is a typical antipsychotic of the butyrophenone family used in the treatment of schizophrenia. It was developed by Janssen Pharmaceutica in 1961 and started its first round of clinical trials in 1963 . In an effort to improve...

  9. Drug

    Gliclazide

    go.drugbank.com/drugs/DB01120
    ApprovedInvestigational

    Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM).

  10. Drug

    AG-858

    go.drugbank.com/drugs/DB05502
    Investigational

    HSP70 associates with antigenic peptides, transporting them into antigen presenting cells (APC) for processing.